PS Ratio
87.57
-3.29-3.62%
100 min ago
Summary
- As of February 6, 2025, XTLB price to sales ratio is 87.57, with a fall of -3.29 (-3.62%) during the most recent trading day.
- XTLB PS ratio is now -62.25% below its all-time high of 231.99.
Performance
XTLB PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
XTLB PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -3.6% | -3.6% | -3.6% | - |
| 1 m1 month | -20.3% | -20.3% | -20.3% | - |
| 3 m3 months | -14.8% | -14.8% | -14.8% | - |
| 6 m6 months | - | -33.5% | +7.6% | - |
| ytdytd | -20.7% | -20.7% | -20.7% | - |
| 1 y1 year | - | +76.9% | +186.1% | - |
| 5 y5 years | - | +7.3% | +83.9% | - |
XTLB PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -23.0% | 46.25 | +89.3% | |
| 3 m | 3-month | 113.71 | -23.0% | 46.25 | +89.3% |
| 6 m | 6-month | 132.21 | -33.8% | 46.25 | +89.3% |
| 1 y | 1-year | 132.21 | -33.8% | 46.25 | +89.3% |
| 3 y | 3-year | 132.21 | -33.8% | 46.25 | +89.3% |
| 5 y | 5-year | 132.21 | -33.8% | 46.25 | +89.3% |
| alltime | all time | 231.99 | -62.3% | 0.20 | >+9999.0% |
XTL Biopharmaceuticals PS Ratio History
| Date | Value |
|---|---|
| 2025 | 87.57(-20.7%) |
| 2024 | 110.45(+5.7%) |
| Date | Value |
|---|---|
| 2006 | 104.48(+149.8%) |
| 2005 | 41.82 |
FAQ
- What is XTL Biopharmaceuticals price to sales ratio?
- What is the all time high PS ratio for XTL Biopharmaceuticals?
- What is XTLB price to sales ratio year-to-date change?
What is XTL Biopharmaceuticals price to sales ratio?
The current PS ratio of XTLB is 87.57
What is the all time high PS ratio for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high price to sales ratio is 231.99
What is XTLB price to sales ratio year-to-date change?
XTL Biopharmaceuticals price to sales ratio has changed by -22.88 (-20.72%) since the beginning of the year